China $6bn Public VC Injection A Boost For Biotech
This article was originally published in PharmAsia News
Executive Summary
The $6.5 billion earmarked for strategic emerging industries comes hot on the heels of a raft of recent announcements that will provide confidence to both domestic and foreign investors.